Top Stories Moximed’s MISHA™ Knee System Treats First Commercial Patients in United States byJosh SandbergSeptember 6, 2023
Recon Regulatory Sports Medicine Top Stories FDA Authorizes Marketing of MISHA™ Knee System for People Suffering from Knee Osteoarthritis byJosh SandbergApril 11, 2023
Sports Medicine Top Stories Moximed’s MISHA™ Knee System Achieves Superiority of Primary Endpoint in Pivotal Study byJosh SandbergSeptember 23, 2022
Financial Sports Medicine Moximed Raises $40 Million to Advance World’s First Implantable Shock Absorber for Knee Osteoarthritis byJosh SandbergAugust 16, 2022
